vs
Ensysce Biosciences, Inc.（ENSC）与Palladyne AI Corp.（PDYN）财务数据对比。点击上方公司名可切换其他公司
Ensysce Biosciences, Inc.的季度营收约是Palladyne AI Corp.的1.1倍（$1.9M vs $1.7M），Palladyne AI Corp.净利率更高（-89.9% vs -147.0%，领先57.2%），Palladyne AI Corp.同比增速更快（118.3% vs 44.4%），过去两年Ensysce Biosciences, Inc.的营收复合增速更高（107.9% vs -30.5%）
Ensysce Biosciences是一家临床阶段生物技术公司，专注于开发疼痛管理和肿瘤适应症领域的创新前药疗法，其专有平台可降低阿片类药物滥用风险并提升治疗有效性，面向全球医疗医药市场，重点解决未被满足的临床需求。
Palladyne AI Corp是一家美国企业，其前身1983年成立时名为萨科斯研究公司，企业长期以来以机器人开发为核心业务。2023年，公司调整业务方向，专注开发适用于机器人场景的人工智能软件，终止了硬件业务，并于2024年3月正式更名为现用名。
ENSC vs PDYN — 直观对比
营收规模更大
ENSC
是对方的1.1倍
$1.7M
营收增速更快
PDYN
高出73.9%
44.4%
净利率更高
PDYN
高出57.2%
-147.0%
两年增速更快
ENSC
近两年复合增速
-30.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.9M | $1.7M |
| 净利润 | $-2.8M | $-1.5M |
| 毛利率 | — | 15.6% |
| 营业利润率 | -147.8% | -560.7% |
| 净利率 | -147.0% | -89.9% |
| 营收同比 | 44.4% | 118.3% |
| 净利润同比 | 22.3% | 97.2% |
| 每股收益（稀释后） | $-0.51 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENSCPDYN
| Q4 25 | $1.9M | $1.7M | ||
| Q3 25 | $493.1K | $860.0K | ||
| Q2 25 | $1.4M | $1.0M | ||
| Q1 25 | $1.3M | $1.7M | ||
| Q4 24 | $1.3M | $761.0K | ||
| Q3 24 | $3.4M | $871.0K | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $3.4M |
净利润ENSCPDYN
| Q4 25 | $-2.8M | $-1.5M | ||
| Q3 25 | $-3.7M | $-3.7M | ||
| Q2 25 | $-1.7M | $-7.5M | ||
| Q1 25 | $-1.9M | $22.8M | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $661.8K | $-7.1M | ||
| Q2 24 | — | $-5.3M | ||
| Q1 24 | — | $-7.2M |
毛利率ENSCPDYN
| Q4 25 | — | 15.6% | ||
| Q3 25 | — | 46.4% | ||
| Q2 25 | — | 53.3% | ||
| Q1 25 | — | 79.4% | ||
| Q4 24 | — | 27.2% | ||
| Q3 24 | — | 45.0% | ||
| Q2 24 | — | 79.0% | ||
| Q1 24 | — | 45.2% |
营业利润率ENSCPDYN
| Q4 25 | -147.8% | -560.7% | ||
| Q3 25 | -758.7% | -937.8% | ||
| Q2 25 | -127.6% | -797.4% | ||
| Q1 25 | -149.1% | -405.3% | ||
| Q4 24 | -274.3% | — | ||
| Q3 24 | 18.9% | -838.0% | ||
| Q2 24 | — | -213.3% | ||
| Q1 24 | — | -213.7% |
净利率ENSCPDYN
| Q4 25 | -147.0% | -89.9% | ||
| Q3 25 | -756.3% | -434.9% | ||
| Q2 25 | -126.4% | -737.6% | ||
| Q1 25 | -147.4% | 1330.9% | ||
| Q4 24 | -273.4% | — | ||
| Q3 24 | 19.4% | -814.7% | ||
| Q2 24 | — | -196.2% | ||
| Q1 24 | — | -210.1% |
每股收益（稀释后）ENSCPDYN
| Q4 25 | $-0.51 | $-0.02 | ||
| Q3 25 | $-1.29 | $-0.09 | ||
| Q2 25 | $-0.79 | $-0.20 | ||
| Q1 25 | $-1.39 | $0.55 | ||
| Q4 24 | $-0.89 | — | ||
| Q3 24 | $1.00 | $-0.27 | ||
| Q2 24 | — | $-0.20 | ||
| Q1 24 | — | $-0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $47.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.2M | $74.7M |
| 总资产 | $7.5M | $95.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ENSCPDYN
| Q4 25 | $4.3M | $47.1M | ||
| Q3 25 | $1.7M | $57.1M | ||
| Q2 25 | $2.2M | $62.7M | ||
| Q1 25 | $3.1M | $46.6M | ||
| Q4 24 | $3.5M | $40.1M | ||
| Q3 24 | $4.2M | $21.3M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | — | $31.8M |
股东权益ENSCPDYN
| Q4 25 | $3.2M | $74.7M | ||
| Q3 25 | $1.2M | $51.8M | ||
| Q2 25 | $3.4M | $53.8M | ||
| Q1 25 | $3.0M | $28.3M | ||
| Q4 24 | $3.7M | $-9.5M | ||
| Q3 24 | $6.9M | $23.4M | ||
| Q2 24 | — | $29.8M | ||
| Q1 24 | — | $34.2M |
总资产ENSCPDYN
| Q4 25 | $7.5M | $95.7M | ||
| Q3 25 | $3.2M | $72.9M | ||
| Q2 25 | $5.6M | $78.3M | ||
| Q1 25 | $4.6M | $63.3M | ||
| Q4 24 | $5.6M | $56.3M | ||
| Q3 24 | $9.4M | $38.7M | ||
| Q2 24 | — | $45.1M | ||
| Q1 24 | — | $50.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-8.7M |
| 自由现金流率自由现金流/营收 | — | -526.2% |
| 资本支出强度资本支出/营收 | — | 14.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ENSCPDYN
| Q4 25 | $-1.5M | $-8.5M | ||
| Q3 25 | $-1.9M | $-6.3M | ||
| Q2 25 | $-2.7M | $-5.3M | ||
| Q1 25 | $-1.7M | $-7.5M | ||
| Q4 24 | $-764.1K | $-22.6M | ||
| Q3 24 | $-1.0M | $-4.5M | ||
| Q2 24 | — | $-5.8M | ||
| Q1 24 | — | $-7.2M |
自由现金流ENSCPDYN
| Q4 25 | — | $-8.7M | ||
| Q3 25 | — | $-6.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $-22.9M | ||
| Q3 24 | — | $-4.5M | ||
| Q2 24 | — | $-5.9M | ||
| Q1 24 | — | $-7.3M |
自由现金流率ENSCPDYN
| Q4 25 | — | -526.2% | ||
| Q3 25 | — | -776.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -445.0% | ||
| Q4 24 | — | -3008.1% | ||
| Q3 24 | — | -517.8% | ||
| Q2 24 | — | -218.9% | ||
| Q1 24 | — | -212.1% |
资本支出强度ENSCPDYN
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | 1.8% |
现金转化率ENSCPDYN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
